Psychedelic Stock Review

Ehave (EVVHF) Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness...

Institutional Review Board (IRB) reviews proposed research protocols to protect human subjects involved in research. MIAMI, July 09,...
Psychedelic Stock Review

Psychedelic Investor Conferences.

Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!

Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.

Here's How Provention's Treatment Works. Interview With an Actual Provention Bio (PRVB) Clinical Trial Participant.
Psychedelic Stock Review

Psychedelic Primer Guide. (Psychedelic Medicine Association)

The Psychedelic Medicine Association (PMA) is a society of physicians, therapists, and health care professionals looking to advance their education on the...
Greenbrook Health

Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence https://youtu.be/yrr-wlFftT0
@bryteeyes3

Citius (CTXR). Dang Flippers!

Short term investors powered Citius from $2.50 to near $4.50 in hopes of a positive early trial...
ehave, psychedelic stock review

Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine...

The FDA Cracks Down On Stem Cell Therapy.

Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold...

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).

Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!

That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...

Redefining how the world approaches, prevents, and heals mental health disorders. LIVE QUOTE

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!